611 Q2W
SSGJ-611-AD-II-01
Phase 2 small_molecule completed
Quick answer
611 Q2W for Dermatitis, Atopic is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Dermatitis, Atopic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed